Immune-mediated polyarthritis (IMPA) is a common disease process in the dog.
Introduction
Immune-mediated polyarthritis (IMPA) is an important disease process in the dog. Inflammation in multiple joints can lead to intense pain and may profoundly affect quality of life. This review article is the first of a two part series. Its aim is to discuss the pathophysiology of IMPA as well as associated syndromes and possible triggers of this immune-mediated disease process.
Pathophysiology
Immune-mediated nonerosive polyarthritis is believed to be driven by a type III hypersensitivity reaction where immune complexes comprised of antigen bound to antibody accumulate in the joint space. Implicated antigens are typically found in the systemic circulation, but can originate from within the joint space itself. [1] [2] [3] Systemic immune complexes can arise from a variety of chronic antigenic stimuli, including (but not limited to) viruses such as the distemper virus, other microbial agents, neoplasia, drug haptens, or even dietary elements. In addition, antibodies directed against self-antigens, such as heat shock proteins, immunoglobulins (rheumatoid factors), and nuclear elements (antinuclear antibodies) can also form complexes that accumulate in the joint space. [1] [2] [3] [4] [5] [6] [7] [8] [9] The presence of immune complexes in the joint space activates complement along the synovial membrane and within the synovial fluid. Complement fixation results in tissue damage and the release of cytokines, some of which attract neutrophils. These neutrophils also release cytokines and lysosomal enzymes that cause further tissue damage. [1] [2] [3] 7 One study showed that there was an increase in CD41 and CD81 T cells in the synovial fluid (compared with the peripheral blood) in dogs afflicted with immune-mediated polyarthritis (IMPA). In addition, the frequency of major histocompatibility complex class II positive cells in the synovium was considerably higher in IMPA patients, suggesting local involvement in the development of inflammation. Proinflammatory cytokines produced by these cells, most notably tumor necrosis factor-a, were found in high concentrations in joint fluid from affected patients and are in fact a target for treatment in human patients with immune-mediated arthritis. 10 In canine rheumatoid arthritis, a disease characterized by erosive joint damage, antibody directed against type II collagen has been found along the joint surface, as well as rheumatoid factors within the joint fluid. 4 The degree of elevation of anti-IgA antibodies can also be used as an indication of the disease severity and prognosis. 4 Antibodies directed against canine distemper virus, heat shock proteins made by distressed cells, and type II collagen have also been found in the joint fluid of dogs with rheumatoid arthritis. 5, 6, 11 It has been hypothesized that the presence of distemper virus in synovial fluid leads to the development of antibodies that crossreact to heat shock proteins, causing sustained inflammation within the joints. 6 The presence of immune complexes and a direct antibody-mediated attack on collagen eventually leads to the erosive changes noted on joint radiographs. 5 Establishing a definitive diagnosis of rheumatoid arthritis is important because this disease has a more guarded prognosis compared with most of the more common nonerosive polyarthropathies.
Nonerosive Polyarthritis
Nonerosive forms of IMPA that lead to neutrophilic inflammation in multiple joints include: idiopathic polyarthritis; vaccine-and drug-induced polyarthritis; polyarthritis/polymyositis syndrome;
steroid-responsive meningitis-arteritis; and breed specific polyarthropathies such as juvenile-onset polyarthritis of Akitas and familial Chinese shar pei fever. Systemic lupus erythematosus (SLE) also commonly involves the joints, but ,20% of canine 
Idiopathic Polyarthritis
Idiopathic polyarthritis refers to all cases of immune-mediated arthropathy that cannot be classified into the other groups previously mentioned. Sporting dogs and large-breed dogs seem overrepresented, and the majority of affected patients are young adults with ages ranging from about 2.5 yr to 4.5 yr. Breeds that are commonly affected include the Labrador retriever, golden retriever, German shepherd dog, cocker spaniel and American Eskimo. [16] [17] [18] [19] Although most retrospective studies have not revealed a sex predisposition, one study noted that females were more frequently affected than males at a ratio of 1.5:1.0. [16] [17] [18] [19] Idiopathic polyarthritis has been categorized into four subtypes: type I (no underlying disease), type II (reactive), type III (enteropathic), and type IV (neoplasia-related). Types II-IV are often grouped together and referred to as the reactive polyarthritides. [1] [2] [3] 7, 16, 17, 20 It should be noted that regardless of subtype, the pathophysiologic change that occurs in the joint space is the same. These subtypes merely point to the presence or absence of a concurrent disease process.
In type I (uncomplicated) polyarthritis, the cause is unknown, and no underlying disease can be detected. This is the most common form of the idiopathic polyarthritides, accounting for approximately 50-65% of all idiopathic polyarthritis cases. 7, 19 In type II (reactive) polyarthritis, an infectious or inflammatory disease distant from the joints is the underlying cause of the polyarthritis. These diseases produce antigens that combine with antibodies to form immune complexes that accumulate in the joints, activating complement, and leading to inflammation. Type IV arthritis is associated with neoplasia that exists outside the joints. This is an uncommon manifestation of idiopathic polyarthritis, occurring in only 2% of 52 dogs with polyarthritis in one study. 19 It has been reported to occur in dogs with neoplasms such as pancreatic adenocarcinoma, renal carcinoma, tonsillar carcinoma, squamous cell carcinoma, mammary carcinoma, leiomyosarcoma, and lymphoma. Neoplasia may act as an antigenic stimulus against which antibodies are formed, leading to circulating immune complexes that deposit in the joint spaces. 3, 7, 20, 22 Vaccine-Induced Polyarthritis given. 25 However, there is no evidence that this protocol prevents vaccine-associated polyarthritis.
In one case series, four young adult dogs were described with suspected vaccine-related polyarthritis occurring within 30 days of vaccinations. 23 All dogs experienced a sudden onset of lameness and several painful and swollen joints 3-15 days after polyvalent booster vaccination. Synovial fluid analysis in affected joints revealed WBC counts reaching 72,000/mL, with the majority of these cells being mature neutrophils. All dogs were treated with doxycycline and nonsteroidal anti-inflammatory drugs, and all recovered within 1-3 days. 23 Vaccine-induced polyarthritis is usually transient, resolving within several days. However, some breeds such as the Akita appear to be predisposed to this condition and suffer a longer course of vaccine-associated polyarthritis. 25 Reports in Akitas describe profound joint pain and cyclic fevers lasting 24-48 hr, with initial signs occurring 3-29 days following vaccination. 25 In over 100 Akita puppies vaccinated with polyvalent modified live vaccines, approximately 10% were reported to experience adverse reactions. These vaccine reactions may be related to the heritable juvenile-onset polyarthritis of Akitas described later in this report.
Prognosis is guarded in affected dogs, which often do not respond to immunosuppressive therapy. 25 
Drug-Induced Polyarthritis
Drug-induced polyarthritis has been reported with multiple different drugs in many different breeds. The most widely reported manifestation occurs secondary to sulfonamide administration, particularly in Doberman pinschers. 9, 26 Other drugs that have been implicated include phenobarbital, erythropoietin, penicillins, lincomycin, erythromycin, and cephalosporins. 1, 20 Typically, the affected animal has either received the inciting drug in the past or has been on the medication long-term. Clinical signs usually resolve within 2-7 days of discontinuing the drug. Reactions associated with sulfonamide in dogs occur an average of 12 days after drug initiation (range, 5-36 days) or from 1 hr to 10 days after drug re-exposure. 9 The delay of $5 days from initial drug exposure to adverse reactions is suggestive of a delayed type IV hypersensitivity response, although the detection of marked complement activation when clinical signs are apparent may be more consistent with a type III sensitivity reaction.
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Polyarthritis/Polymyositis Syndrome Polyarthritis/polymyositis syndrome is characterized by polyarthritis initially accompanied with focal or generalized muscle pain and swelling followed by eventual muscle atrophy and fibrosis.
Most recorded cases of polyarthritis/polymyositis syndrome have been identified in spaniels. Bennett and Kelly described six cases occurring in two Cavalier King Charles spaniels, two springer spaniels, one cocker spaniel, and one whippet. 28 None of those dogs had a positive antinuclear antibody titer, making them less likely to have SLE. 28 Initially, polyarthritis/polymyositis syndrome causes muscle swelling and pain, but eventually leads to muscle atrophy and ultimately fibrosis and contracture, resulting in limited joint mobility. Animals present with fever and painful joints and muscles. Muscle enzymes, including creatine kinase, are often elevated, and diagnosis is based on the combination of electromyography, muscle biopsies, and joint taps. 2, 28 Immunofluorescent studies of the synovium of affected dogs show IgG, IgM, and complement associated with macrophages and deposited within synovial vessels. In addition, IgG deposits on the sarcolemmal membranes were often demonstrated on muscle biopsy. 28 
Steroid-Responsive Meningitis-Arteritis
Steroid-responsive meningitis-arteritis (SRMA) is currently the most widely accepted term describing a disease syndrome that causes meningitis in medium-and large-breed dogs ,2 yr of age. 29 The syndrome was first recognized in young laboratory beagles and was referred to as "beagle pain syndrome." Canine pain syndrome, canine juvenile polyartertis syndrome, canine meningeal polyarteritis, aseptic suppurative meningitis, and necrotizing vasculitis are also terms that have been used to describe essentially the same disease condition. 29 Other breeds that are predisposed to SRMA include the boxer, Bernese mountain dog, Nova Scotia Duck tolling retriever and German shorthaired pointer.
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Typically, affected animals present with an acute onset of neck pain, fever, and lethargy. Juvenile-Onset Polyarthritis of Akitas and platelets) and, to a lesser degree, type IV (cell-mediated activity against self-antigen) hypersensitivities. 42, 45 In general, a combination of abnormal immune activity, loss of self tolerance, and an antigenic trigger appear to be necessary for SLE to arise.
Triggers are thought to be multifactorial and may include genetic predisposition and/or exposure to infectious agents, ultraviolet light, and certain drugs. 44 Interestingly, the prevalence of SLE among pet dogs owned by SLE human patients was estimated at .500/10,000 dogs (5%). The prevalence of SLE in the general dog population is only 0.03%, suggesting that a common environmental factor or zoonotic agent may be involved in the development of human and canine SLE. 42, 44 Clinical findings can be separated in two main categories 
Conclusion
Neutrophilic inflammation in multiple joints can be associated with a wide variety of disease processes. Determining the underlying cause or complete disease syndrome is important when considering treatment and prognosis. In the second part of this series of review articles, the diagnostic approach to patients with suspected IMPA will be discussed, along with treatment options, monitoring parameters, and prognostic indicators.
